Amendments › HF 2492

Amendment H-8050 to HF 2492

Relating to insurance coverage for biomarker testing

Never voted on

Filed February 26, 2024 in the House by

What it changes

  1. Page 1, after line 7 by inserting: “___. Page 2, by striking lines 16 and 17 and inserting “testing has demonstrated clinical utility, or when the biomarker testing is considered to be a medically necessary service for coverage pursuant to subsection 5, paragraph “b” , provided that biomarker test results that provide information that is used in the formulation of a treatment or monitoring strategy that informs a covered person’s outcome and impacts the clinical decision shall be considered medically necessary services pursuant to subsection 5, paragraph “b” , including but not limited to any of the following:””
  2. By renumbering as necessary.

Official amendment (PDF) · In the Bill Book